Free Daily Podcast Summary
Galaxy Balance: Daily Summaries Delivered
by Cory Smith
Galaxy Balance explores the frontier where biology, technology and consciousness meet. Each episode brings together pioneers shaping our collective future, from genome engineers and AI builders to longevity researchers, space explorers, and mindfulness practitioners. Hosted by Cory Smith, the conversations dive deep into how these seemingly distant fields form an interconnected ecosystem, one that balance innovation with introspection, science with spirit, and ambition with awareness. At its core, Galaxy Balance is about integration; the idea that our greatest leaps forward happen when disciplines collide. The same algorithms that decode galaxies can help us understand genomes; the same principles that govern consciousness can illuminate AI. Through long-form, unscripted dialogue, the show invites listeners to zoom out from the silos of specialization and see the larger pattern: a living system of intelligence evolving across scales – molecular, planetary, and cosmic.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 2 weeks ago1h 0m
The Science and Choices Behind De-Extinction
Ancient DNA can reveal how extinct species lived and evolved. New tools in genome engineering and reproductive biology may make it possible to recreate some of their traits, and to help endangered species adapt to changing environments.Beth Shapiro, evolutionary molecular biologist and chief science officer at Colossal Biosciences, joins Galaxy Balance to discuss what de-extinction means in practice. We explore how researchers select traits from mammoth and elephant genomes, engineer many edits in elephant cells, and use different approaches for mammals and birds. Beth also explains how her team weighs animal welfare and genetic risk, why the direwolves were given light coats through a safer genetic route, and how local communities, Indigenous groups, and regulators can shape conservation plans.The conversation covers the limits of ancient DNA, tools such as Genomorph, and the potential for technologies developed through de-extinction research to support biodiversity and conservation.00:43 — Introduction to Dr. Beth Shapiro and the promise of de-extinction01:55 — Beth’s path into ancient DNA and the appeal of reconstructing extinct worlds03:31 — Why ancient DNA inspired Jurassic Park, not the other way around04:20 — The first ancient-DNA breakthrough and the limits of recovering very old DNA06:39 — Why mammoths became a central de-extinction target08:50 — From early DNA sequencing to modern genomic tools12:04 — How mammoth traits are selected from elephant and mammoth genomes14:21 — Turning genetic differences into traits: hair, fat, ears, tails, and tusks17:12 — Multiplex editing: making many genetic changes at once19:29 — Genome integrity, off-target edits, and selecting healthy cell lines24:11 — From edited cells to animals: cloning mammals and engineering birds27:42 — The reproductive challenges of making mammoths and helping elephants30:40 — Advancing bird genetics for dodo, moa, and conservation work33:16 — Genetic rescue: engineering cane-toad-resistant quolls35:31 — Regulation, local communities, and responsible phased releases37:12 — Indigenous leadership and the moa restoration project39:29 — Beth’s proudest achievement: expanding genetic tools for birds44:06 — Can we restore traits without ancient DNA? The dire wolf example48:09 — Why dire wolves will not be released into the wild51:21 — Conservation over novelty: using genome editing to address biodiversity loss53:49 — The biggest remaining technological hurdles56:33 — “Playing God,” human responsibility, and shaping a biodiverse future58:05 — Science-fiction recommendations and the enduring warning of Jurassic Park
- 3 weeks ago1h 0m
The Medicine of Human Contact
Premature babies enter the world before many of their biological systems are ready, yet the technologies that keep them alive often separate them from their parents. Alon Metrikin-Gold, founder and CEO of NEOCare, is working to redesign neonatal care around connection.His team developed SKINcubator, a wearable medical device intended to enable immediate and prolonged skin-to-skin care for premature and medically fragile infants. The device maintains warmth and humidity while securing the baby and supporting the lines and tubes required in intensive care.In this episode, we explore why separation is not a neutral baseline, how physical contact affects stress regulation and development, and why parents should be treated as part of the clinical care team. 00:00 - Introduction to Skincubator Neocare and the problem of prolonged skin-to-skin care01:11 - Alon’s background in women’s health and medical anthropology03:03 - The key insight: separation is the artificial state04:45 - WHO guidance versus actual NICU practice06:14 - What parents and nurses revealed about failed skin-to-skin care07:49 - Why extremely premature babies are so fragile09:46 - The early engineering idea: heat and humidity from the parent’s body10:43 - Six core design requirements for the first week of life11:42 - What “transfer” means in practice and why it is so stressful13:07 - Line safety, hypothermia, and why short sessions still fail14:32 - How the device maintains heat, humidity, safety, and access15:02 - Early clinical results and hours of skin-to-skin care achieved16:19 - Target population and why the first days of life matter most17:15 - Why NICU care often leaves parents unsure of their role18:12 - How the broader system is built around separation19:10 - Why skin-to-skin care is not just “nice,” but medically significant21:06 - Human connection as something technology should support, not replace22:04 - FDA breakthrough designation and what it means23:32 - Why better documentation of skin-to-skin care matters24:31 - How the device becomes a catalyst for protocol change26:35 - The biology of stress reduction, cortisol, and stabilization28:03 - Skin-to-skin care as preventative medicine and neurodevelopment support30:28 - Maternal and infant benefits, including feeding and sensory regulation31:25 - Designing as a producer, not an engineer, and listening to nurses32:47 - Building for two user groups at once: parents and nurses34:44 - How aesthetics, regulation, business model, and manufacturing all connect36:29 - Funding the company with angels and seed capital37:25 - Clinical expansion plans in Europe, Germany, Canada, Poland, Australia, and the US38:10 - Safety, feasibility, and randomized trials focused on increased contact time39:34 - Future outcome studies: baby, parent, nurse, hospital, and ROI measures41:50 - The long-term roadmap: connected care from delivery to discharge43:48 - Quantifying skin-to-skin barriers and the challenge of measurement44:46 - Why parents occupy both patient and labor roles in the NICU46:36 - Three strategic arcs: discharge, parent engagement, and low-resource settings47:14 - Parenting, stress, and the emotional reality of the NICU49:32 - Reimbursement, leave policies, and institutional barriers for families55:13 - Advice for medical device founders: solve the problem, not the idea56:42 - Why medical devices require technology, regulatory, and business model alignment57:30 - Collecting data early to validate the next step58:59 - Alon’s science fiction and urban fantasy recommendation
- Sep 23, 202659 min
Can We Build Virus-Proof Life?
What happens when scientists rewrite the genetic code that nearly all life on Earth shares?Dr. Akos Nyerges, a genome engineer and independent research group leader at Harvard Medical School, joins Galaxy Balance to explore the emerging world of synthetic genomes. His lab is engineering bacteria with altered genetic codes that can resist viral infection, restrict the exchange of genetic information, and incorporate chemical building blocks beyond biology’s standard 20 amino acids.Akos explains how these genetic firewalls could make engineered organisms safer for drug delivery, biomanufacturing, and environmental applications. We examine why large-scale genome rewriting often produces sick cells, how multi-omics can reveal hidden errors such as accidental promoters and mistranslated proteins, and how his team restored recoded bacteria to near-normal fitness.The conversation also explores AI-assisted genome design, cloud laboratories, engineered living medicines, horizontal gene transfer, the risks of mirror life, and the regulatory frameworks needed as synthetic biology moves toward increasingly ambitious forms of life.Could we create organisms isolated from the rest of nature? Can evolution overcome even our strongest genetic firewalls? And how close is modern genome engineering to becoming science fiction made real?00:00 Introduction01:16 Akos’s Path to Synthetic Biology03:59 Engineering the Genetic Code05:45 Three Goals for Synthetic Biology09:16 Controlling Horizontal Gene Transfer11:11 Building a Genetic Firewall13:39 Toxicity of Recoded tRNAs14:26 Drug Delivery and Bioremediation16:22 Solving the Fitness Problem18:35 Measuring Real Biological Fitness20:13 Testing Virus Resistance23:37 Why the Genetic Code Is Universal26:42 From Recoding to Applications28:52 Debugging Genomes With Multiomics31:15 Hidden Bugs in Genome Design35:33 AI for Genome Design37:51 Can LLMs Recode Genomes?40:06 Building Local AI Compute42:18 Cloud Labs and CROs45:52 From Lab to Commercial Use47:26 Translational Research and IP48:44 Expanding Biology’s Chemical Alphabet49:59 Ethics, Biosafety, and Regulation53:23 The Risks of Mirror Life57:37 When Science Fiction Becomes Real58:33 Closing and Hiring Announcement
- Sep 7, 20261h 7m
Humanity May Become the Little Green Men
If the universe contains billions of potentially habitable worlds, where is everybody?Dr. Terry Adair, author of Where Are the Little Green Men? The Adair Hypothesis, joins Galaxy Balance to examine the Fermi paradox through the lens of energy. His hypothesis proposes that an advanced technological civilization requires access to an abundant, dense, storable, transportable, and scalable energy supply.The conversation traces Earth’s energetic evolution from hydrothermal chemistry and photosynthesis to fire, fossil fuels, nuclear fission, and fusion. Terry explains how photosynthesis enabled complex life while also creating the ancient reserves of coal, oil, and natural gas that eventually powered industrial civilization. He argues that this unlikely sequence may represent a series of filters preventing intelligent life elsewhere from producing detectable technology or reaching other stars.We also explore the Drake equation, abiogenesis, the evolution of complex life, the technological limitations of ocean worlds, the challenges surrounding red dwarf stars, and the laws of thermodynamics that constrain every possible civilization. Terry outlines how fusion energy could eventually enable plasma drives, antimatter production, and spacecraft capable of reaching a meaningful fraction of the speed of light.The episode closes with an optimistic vision of humanity’s long-term future. If we continue expanding our scientific knowledge and energy capabilities, humans may eventually become the interstellar visitors that other civilizations look toward the sky hoping to find.00:00 - Why the Fermi paradox belongs at the center of this conversation03:37 - How Adair’s background led him to an energy-based hypothesis04:20 - What the Fermi paradox actually means08:14 - Drake equation, exoplanets, and the Great Filter10:23 - Why the Drake equation is a framework, not an exact answer11:47 - Why abiogenesis and intelligence are not the same question13:29 - Earth’s evolutionary milestones from microbes to technology15:10 - Why photosynthesis is the breaking point in life’s history18:28 - The difference between abundant energy and usable energy21:49 - Endosymbiosis, mitochondria, and the energy jump in complex life23:51 - Why CO2 is the raw material behind plant structure26:19 - How biomass became coal, oil, and natural gas29:25 - Where uranium and thorium come from31:46 - Why nuclear fusion is central to future civilization33:34 - Entropy, disorder, and why perpetual motion fails38:03 - The limits of fossil fuels and the case for nuclear fission40:02 - Weapons, waste, and why small modular reactors matter43:20 - The Adair Hypothesis, defined44:14 - Fire as humanity’s first technology47:27 - The photosynthetic trap and why fossil fuels changed civilization49:58 - How much energy humanity has burned in 200 years51:21 - Could an aquatic species build technology without fire?52:32 - From Democritus to quarks: what matter really is56:22 - Why energy access on Earth is still an equity issue58:51 - Antimatter, plasma drives, and propulsion limits62:47 - Why fusion-powered travel is a 300 to 400 year project64:21 - Humans as the future “little green men”65:21 - Why Star Wars is Adair’s favorite science fiction reference
- Aug 24, 20261h 3m
Can We Make a Drug for One Person?
What if we could design a medicine for a single person?Casey McPherson was a musician and songwriter when his daughter Rose was diagnosed with an ultra-rare neurogenetic disease. There was no approved treatment and no clear path forward. Rather than accepting that answer, Casey began learning genetics, building a network of scientists, and ultimately creating the infrastructure needed to develop a treatment for his daughter.Today, Casey is the CEO and co-founder of Alpha Rose Therapeutics, where his team is working to make individualized genetic medicine scalable. Their approach combines antisense oligonucleotides, patient-derived stem cells, AI-guided therapeutic design, automation, and a new economic model for diseases that traditional drug development often leaves behind.We discuss how Alpha Rose reduced a therapeutic amenability analysis that once took months to just minutes using AI, why Casey believes drug development should eventually be approved as a repeatable process rather than one drug at a time, and how point-of-care synthesis could allow personalized genetic medicines to be produced rapidly for individual patients.We also explore autonomous laboratories, AI scientists, patient-derived iPSCs and brain organoids, the economics of rare disease, genetic enhancement, and a future of medicine that looks increasingly like the sick bay of Star Trek: understand the unique biology of the patient, design the intervention, synthesize it, and treat them.Casey's story raises a much bigger question. Are rare diseases really rare, or are they the first glimpse of a future where every disease becomes individualized? 00:00 - Casey McPherson’s path from musician to biotech founder01:38 - Childhood curiosity: music, programming, electronics, and biology04:16 - Rose’s diagnosis and the end of the traditional care pathway07:46 - Learning the problem was bigger than one child09:59 - Why a foundation and ecosystem had to come first11:27 - Why Rare Labs was built as a modality agnostic discovery lab12:24 - Why antisense oligonucleotides made sense for Rose13:22 - Designing and filtering thousands of ASO candidates15:13 - Building patient-specific iPSCs and brain organoids17:25 - Why animal models are mainly a safety tool20:06 - Why Alpha Rose became a public benefit corporation23:22 - Regulatory strategy and the path toward a small patient trial27:35 - How Casey learned drug development by doing30:30 - The AI amenability study workflow for new patients33:24 - Turning a rough AI prototype into a validated internal tool35:34 - Using the tool on every new drug and patient case36:31 - Why speed matters when families are waiting on treatment37:54 - Rare disease as a business model problem, not just a science problem43:02 - The next decade of individualized medicine44:27 - Process approval and point-of-care drug synthesis46:34 - Beyond rare disease: enhancement and broader applications48:24 - Why children’s health is so underfunded51:20 - Why precision medicines can lower development risk53:33 - Robotics and the fully automated lab of the future55:46 - Renee, conversational AI, and the scientist-as-assistant future56:54 - Science fiction influence and the Star Trek medicine model59:50 - Advice for families and scientists facing genetic disease1:02:21 - Closing thoughts on individualized disease
- Aug 10, 20261h 6m
Clarice Aiello: The Hidden Quantum Physics of Biology
Could life be using quantum physics to sense the world, regulate cellular processes, and respond to magnetic fields?Clarice Aiello is a quantum engineer, Chair of the Board and Chief Scientific Officer at the Quantum Biology Institute, and the founder of the former Quantum Biology Tech Lab at UCLA. Her research explores whether living systems harness quantum phenomena once considered too fragile to survive within warm, noisy cells.In this episode of Galaxy Balance, Clarice explains quantum tunneling, superposition, entanglement, and decoherence through the lens of biology. We discuss how electrons inside proteins may function as nature-made quantum sensors, how weak magnetic fields can influence cellular behavior, and whether engineered magnetic fields could eventually support wound healing, regeneration, and other forms of electromagnetic medicine.Clarice also describes the evidence that birds may use quantum sensing to navigate, why nature could teach us to build better quantum technologies, and how altered magnetic environments may affect organisms traveling to the Moon or Mars. We explore the scientific standards needed to move quantum biology into the mainstream, the limits of current evidence, and the possibility of creating a Star Trek-style tricorder that interacts with biology through precisely designed magnetic fields.The conversation closes with quantum literacy, science fiction, interdisciplinary research, and Clarice’s advice for the next generation of scientists entering one of biology’s strangest emerging frontiers.0:00 Clarice Aiello’s background and why quantum biology matters7:12 The long-term vision for magnetic-field-based therapeutics10:30 Why the field still lacks depth, breadth, and standards15:30 What quantum physics is, in plain language19:01 Superposition explained with dimmer-switch logic26:19 Why decoherence limits quantum effects in warm, wet cells29:27 What counts as evidence for quantum biology today32:24 Skepticism about entanglement, microtubules, and consciousness claims34:37 The double-slit experiment and why observation is often misunderstood37:11 Mars, the Moon, and why magnetic fields may matter for colonization41:37 How weak magnetic fields may work at the protein level44:36 Spin-dependent chemical reactions and biological branching53:14 Why Clarice thinks nature is effectively a quantum engineer58:13 Science fiction, Recursion, and what it gets right and wrong about observation59:05 Why quantum literacy should be part of basic education
- Jul 27, 202657 min
Li Li: Rewiring Skin Aging With AI and mRNA
00:00 - Introduction to Lily and GLife’s vision for data-driven dermatology01:20 - Lily’s scientific background 02:43 - Breakthroughs from single-cell atlases03:50 - The motivation behind founding GLife 04:50 - The importance of treating skin as a foundational organ 05:48 - Discovery of key molecular drivers of aging 06:22 - Challenges of fundraising07:45 - The novel approach to rejuvenating hair loss through targeted messenger RNA treatments08:53 - How treatments will be delivered via microneedles and micro patches09:32 - The potential to alter hair color and explore cosmetic applications10:06 - Balancing platform discovery engines with the development of first-in-class therapeutics10:43 - The comprehensiveness of the skin atlas and addressing genetic diversity11:39 - Technical challenges of capturing skin’s cellular heterogeneity and stem cell populations12:50 - The importance of isoforms and deep sequencing in understanding gene functions13:16 - Short-lived messenger RNA as a safe, reversible treatment modality14:55 - Safety considerations and toxicity management 16:01 - Biodistribution studies and local micro-needle delivery safety17:00 - Next steps towards clinical trials and regenerative therapies for hair loss18:08 - The role of big data and omics in understanding skin disorders and aging19:04 - The significance of isoforms in skin biology and gene function20:13 - Endogenous vs. modified messenger design for safety and efficacy21:32 - Potential for multi-gene delivery to enhance hair regrowth and color restoration22:22 - Conception of patches that work with existing hair without shaving23:38 - Targeting broad hair loss types and the concept of root causes24:47 - Modeling hair loss with animal models and regulatory considerations25:48 - Regulatory perspectives on non-animal models and validation strategies26:34 - The interplay between genetic and environmental causes of skin aging27:54 - The biological hub role of specific transcription factors in stress and aging29:10 - The future of skin biomarkers for diagnosis and personalized health monitoring30:18 - Leveraging AI’s data integration and precision medicine in dermatology32:32 - The impact of protein isoforms and post-translational modifications in skin treatment34:47 - Interest in peptides, small molecules, and biohacking trends for skin health36:03 - Collaboration between wet labs, computational teams, and clinical partners36:36 - The significance of internal naming conventions in research and development37:28 - The high-throughput screening process for key transcription factors38:13 - Strategies for overexpressing target genes in therapeutic design39:00 - AI’s role in accelerating discovery and development pipelines in biotech40:39 - Addressing data quality, heterogeneity, and integration challenges in big datasets44:12 - Envisioning personalized skincare driven by genomics and AI44:56 - The inspiring concept that ancient technologies now seem like magic45:24 - Challenges in bringing novel dermatological treatments through trials and regulation47:42 - The evolving role of AI in drug quality control and documentation48:11 - Unique advantages of Lily’s targeted mRNA approach over other modalities49:22 - Using skin as a model system for broader human biology insights50:28 - Perspectives on epigenetic reprogramming and cellular re-differentiation51:22 - Fundraising experiences and strategic positioning for biotech development52:21 - The influence of science fiction, especially “Three Body Problem” and “Interstellar,” on Lily’s vision54:24 - Advice to young scientists: read widely, think deeply, and dream big
- Jul 13, 20261h 3m
Aditya Kunjapur: Bringing New Chemistry to Life
What does it take to bring new chemistry to life?In this episode of Galaxy Balance, Cory Smith speaks with Aditya Kunjapur, Associate Professor of Chemical and Biomolecular Engineering at the University of Delaware, about genetic code expansion, non-standard amino acids, engineered microbes, and the future of synthetic biology.Aditya’s lab explores how biology can be programmed to biosynthesize chemical groups that are rare or absent in nature, install those new building blocks into proteins, and make microbial survival depend on synthetic chemistry. The conversation moves from his early path through energy and chemical engineering, to his time in George Church’s lab, to the founding of Nitro Biosciences and the use of expanded genetic codes for next generation vaccine platforms.They discuss how non-standard amino acids can act as chemical flags for the immune system, how live microbes could produce antigens inside the body, and why genetic code expansion may open new approaches to vaccines, biocontainment, agriculture, environmental engineering, and planetary protection.The episode also explores synthetic auxotrophy, engineered microbial dependence, plant controlled microbial survival, plastic degradation, agricultural probiotics, bioenergy, AI tools for non-standard amino acids, and the science fiction lessons behind containment, from Jurassic Park to modern AI.This is a conversation about rewriting the language of life, not only to understand biology, but to give it new chemistry, new safeguards, and new possibilities.Timestamps:00:00 - Engineering microbes for space: Bacillus subtilis and biological containment02:28 - Aditya’s pathway into synthetic biology and innovative chemistry05:46 - Transitioning from industry internships to academia and entrepreneurship10:16 - Founding Nitro Biosciences: balancing entrepreneurship with academic research16:31 - Genetic code expansion and its potential to elicit immune responses22:41 - The scarcity and potential of non-standard amino acids in life27:26 - Detecting extraterrestrial life and the shared building blocks of biology36:49 - Synthetic oxytrophy and microbial biocontainment strategies44:01 - Reducing herbicide reliance with engineered microbes in agriculture52:53 - Computational tools and AI for non-standard amino acid research54:53 - Bioenergy and sustainability: bio-catalysis innovations59:08 - How science fiction influences bioengineering and AI safety considerations
Get Galaxy Balance summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
Inquiring Minds
Explores the intersection of science and society through critical thinking and in-depth analysis.
The Biohacking Standards
A deep dive into biohacking fundamentals—nutrition, movement, sleep, and mindfulness—grounded in science and holistic wellness principles.
The Cellular Upgrade
Explores the connection between cellular health, consciousness, and personal transformation through science and spirituality.
Mayim Bialik's Breakdown
Explores the intersection of science and spirituality through conversations on consciousness, healing, and unexplained phenomena.
The World, the Universe and Us
Explores big scientific questions about life, consciousness, climate, and the cosmos with expert scientists and New Scientist journalists.
Sean Carroll's Mindscape: Science, Society, Philosophy, Culture, Arts, and Ideas
Conversations with leading thinkers exploring fundamental ideas in science, philosophy, culture, and the arts.
Science Friday
Explores diverse science and technology topics, from space to microscopic life, with engaging educational stories.
Huberman Lab
Explores neuroscience and science-based tools for understanding and improving brain function, behavior, and health.
A Question of Science
Experts answer public questions on pressing scientific issues, from cancer and nutrition to AI and climate change.
Inner Cosmos with David Eagleman
Neuroscientist David Eagleman examines how the brain interprets reality through science, stories, and interviews.
Brave New Planet
Explores the societal and ethical impacts of emerging technologies like AI and genetic engineering through expert conversations.
From Our Neurons to Yours
Discusses neuroscience research and its implications for understanding the brain and treating neurological conditions.
About Galaxy Balance
Galaxy Balance explores the frontier where biology, technology and consciousness meet. Each episode brings together pioneers shaping our collective future, from genome engineers and AI builders to longevity researchers, space explorers, and mindfulness practitioners. Hosted by Cory Smith, the conversations dive deep into how these seemingly distant fields form an interconnected ecosystem, one that balance innovation with introspection, science with spirit, and ambition with awareness. At its core, Galaxy Balance is about integration; the idea that our greatest leaps forward happen when disciplines collide. The same algorithms that decode galaxies can help us understand genomes; the same principles that govern consciousness can illuminate AI. Through long-form, unscripted dialogue, the show invites listeners to zoom out from the silos of specialization and see the larger pattern: a living system of intelligence evolving across scales – molecular, planetary, and cosmic.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from Galaxy Balance in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's Galaxy Balance daily summary?
It's a free AI-powered email that summarizes new episodes of Galaxy Balance as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the Galaxy Balance podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official Galaxy Balance product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Cory Smith.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
How often does Galaxy Balance release new episodes?
Galaxy Balance publishes biweekly. Our AI generates a summary within hours of each new episode.
What topics does Galaxy Balance cover?
Galaxy Balance covers topics including Science, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting Galaxy Balance summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.